These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 21772013)

  • 1. Combined surgical left ventricular reconstruction and left ventricular assist device implantation for destination therapy in end-stage heart failure.
    Garbade J; Bittner HB; Barten MJ; Rastan A; Lehmann S; Mohr FW; Borger MA
    Circ Heart Fail; 2011 Jul; 4(4):e14-5. PubMed ID: 21772013
    [No Abstract]   [Full Text] [Related]  

  • 2. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
    Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
    J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First clinical implant of the VentrAssist left ventricular assist system as destination therapy for end-stage heart failure.
    Esmore DS; Kaye D; Salamonsen R; Buckland M; Rowland M; Negri J; Rowley Y; Woodard J; Begg JR; Ayre P; Rosenfeldt FL
    J Heart Lung Transplant; 2005 Aug; 24(8):1150-4. PubMed ID: 16102463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left ventricular assist devices as destination therapy: a new look at survival.
    Park SJ; Tector A; Piccioni W; Raines E; Gelijns A; Moskowitz A; Rose E; Holman W; Furukawa S; Frazier OH; Dembitsky W
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):9-17. PubMed ID: 15632819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experience of left ventricular assist device "Incor" as "bridge to recovery" implantation in patients with end stage congestive heart failure].
    Khubulava GG; Ivchenko EV; Paĭvin AA; Kravchuk VN; Iurchenko DL; Ivashchenko AI; Didenko MV; Luk'ianov NG; Peleshok AS; Tsygan NV; Liubimov AI; Naumov AB; Shorokhov KH; Sukharev AE; Kniazev EA; Porembskaia IA
    Voen Med Zh; 2011 Nov; 332(11):29-35. PubMed ID: 22329169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac transplantation for cardiac sarcoidosis with initial diagnosis by examination of the left ventricular apical "core" excised for insertion of a left ventricular assist device for severe chronic heart failure.
    Roberts WC; Vowels TJ; Ko JM; Capehart JE; Hall SA
    Am J Cardiol; 2009 Jan; 103(1):110-4. PubMed ID: 19101239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular assist device in severe heart failure: effects on cytokines, complement and body weight.
    Clark AL; Loebe M; Potapov EV; Egerer K; Knosalla C; Hetzer R; Anker SD
    Eur Heart J; 2001 Dec; 22(24):2275-83. PubMed ID: 11728148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term use of a left ventricular assist device for end-stage heart failure.
    Rose EA; Gelijns AC; Moskowitz AJ; Heitjan DF; Stevenson LW; Dembitsky W; Long JW; Ascheim DD; Tierney AR; Levitan RG; Watson JT; Meier P; Ronan NS; Shapiro PA; Lazar RM; Miller LW; Gupta L; Frazier OH; Desvigne-Nickens P; Oz MC; Poirier VL;
    N Engl J Med; 2001 Nov; 345(20):1435-43. PubMed ID: 11794191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Surgical strategy for severe heart failure].
    Sawa Y
    Nihon Geka Gakkai Zasshi; 2006 Jan; 107(1):27-32. PubMed ID: 16482893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Destination nowhere: a potential dilemma with ventricular assist devices.
    Bramstedt KA
    ASAIO J; 2008; 54(1):1-2. PubMed ID: 18204307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device placement in a patient with end-stage heart failure and human immunodeficiency virus.
    Fieno DS; Czer LS; Schwarz ER; Simsir S
    Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):919-20. PubMed ID: 19706718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.
    Grady KL; Meyer PM; Dressler D; Mattea A; Chillcott S; Loo A; White-Williams C; Todd B; Ormaza S; Kaan A; Costanzo MR; Piccione W
    Ann Thorac Surg; 2004 Apr; 77(4):1321-7. PubMed ID: 15063260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement.
    Soderlund KA; Chivukula RR; Russell SD; Conte JV; Mudd JO; Halushka MK
    Cardiovasc Pathol; 2009; 18(4):217-22. PubMed ID: 18706833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical closure of left ventricular outflow tract after left ventricular assist device implantation in patients with aortic valve pathology.
    Cohn WE; Demirozu ZT; Frazier OH
    J Heart Lung Transplant; 2011 Jan; 30(1):59-63. PubMed ID: 20884246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Destination therapy with left ventricular assist devices: patient selection and outcomes.
    Slaughter MS; Meyer AL; Birks EJ
    Curr Opin Cardiol; 2011 May; 26(3):232-6. PubMed ID: 21430527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Permanent left ventricular assist device for end-stage heart failure: first successful implantation of the axial flow HeartMate II rotary pump as destination therapy for heart failure in Israel.
    Amir O; Aravot D; Pizov R; Orlov B; Eden A; Shiran A; Karkabi B; Sabbag L; Zlotnick AY; Ammar R; Halon DA; Lewis BS
    Isr Med Assoc J; 2007 Dec; 9(12):887-8. PubMed ID: 18210934
    [No Abstract]   [Full Text] [Related]  

  • 19. Right-to-left ventricular end-diastolic diameter ratio and prediction of right ventricular failure with continuous-flow left ventricular assist devices.
    Kukucka M; Stepanenko A; Potapov E; Krabatsch T; Redlin M; Mladenow A; Kuppe H; Hetzer R; Habazettl H
    J Heart Lung Transplant; 2011 Jan; 30(1):64-9. PubMed ID: 21036066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ventricular assist device therapy.
    Sayer G; Naka Y; Jorde UP
    Cardiovasc Ther; 2009; 27(2):140-50. PubMed ID: 19426251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.